Author Archive

Andy Snyder

Managing Director

Read more about the author

Urology – Q1 2022 Acquisition Activity and Outlook

The first quarter of 2022 delivered three reported urology practice acquisitions, continuing a pattern of smaller deal volume and larger deal size when compared to other practice specialties undergoing M&A consolidation.
Ophthalmology 1Q 2022

Ophthalmology – Q1 2022 Acquisition Activity and Outlook

The first quarter of 2022 delivered eleven reported ophthalmology practice acquisitions, marking a sharp decline from the flurry of closings at the end of last year This was expected as business development teams had exhausted all resources toward closing deals last quarter We will highlight a few notable deals.

Home Health & Hospice – Q1 2022 Acquisition Activity and Outlook

The first quarter of 2022 delivered twenty-eight reported home health and hospice acquisitions, coming down from peaks levels to end the past year However, Q1 has historically brought lower M&A levels, and we expect deal volume to rebound throughout the year.

Gastroenterology – Q1 2022 Acquisition Activity and Outlook

The first quarter of 2022 delivered ten reported gastroenterology practice acquisitions, continuing the high level of M&A activity we saw last year Several deals were announced in the first few weeks of the year, likely spilling over from efforts to close in 2021.

Behavioral Health – Q1 2022 Acquisition Activity and Outlook

The first quarter of 2022 delivered thirty-five reported behavioral health acquisitions, returning to average deal volume after a spike in activity to end 2021. Mental health and addiction treatment continue to be at the forefront of consolidation. We will highlight a few notable deals from the period.